At #STATSummit, three parents discussed the challenges they've faced trying to find treatments for their children with rare ...

Longtime journalist Lawrence Ingrassia embarked on a scientific odyssey to understand why members of his family were dying so ...

Led by Sen. Dick Durbin of Illinois, senators question if direct-to-consumer website telehealth deals are a new way around ...

Opinion: Abortion providers are overwhelmed with patients from states with restrictions. Increasing abortion training for ...

Most pharmaceutical executives didn't donate to political candidates in the lead-up to the election. But the ones who did ...

The emails from inside a physician practice owned by UnitedHealth Group sounded cheery, but were all business.

That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer ...

Experts advising on dietary guidelines say it's premature to tackle ultra-processed foods. "In the next five years, research ...

A Pfizer result is unsettling the gene therapy push for Duchenne muscular dystrophy: The boys didn't improve even though a ...

It began with a burning pain in her right eye. At first, Elisabeth Cohen thought she’d gotten something in it. But the next ...

It is in the public’s best interest for the president and candidates to receive confidential medical care, writes ethicist ...

Confounding data from a Pfizer clinical trial have rattled the field of gene therapy for Duchenne muscular dystrophy ...